Department of Pharmaceutical Sciences, University of Connecticut, United States
Commentary
Critical Differences in Generics and Biosimilars
Author(s): Richard Dang*
DOI:
10.37421/2167-7689.2021.10.275
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 